Soha Helal Distribution Company, affiliated with the Medical Procurement Organization of the Red Crescent Society, which has now become one of the main pillars of pharmaceutical distribution across the country, has placed comprehensive development programs on its agenda, focusing on diversifying its product portfolio, optimizing logistics, and increasing profit margins.
According to the report of the Public
Relations and International Affairs Unit of the Medical Procurement
Organization, this company, which began its activities with the fundamental
motto of "Alleviating Human Suffering," now plays an effective role
in the equitable distribution of medicine, particularly in deprived and underprivileged
areas, by extending its distribution network to 18
provinces
across the country.
Scope of Services and Social
Responsibility
Soha Helal Distribution Company
currently operates distribution centers in strategic provinces including East
Azerbaijan, Ardabil, Isfahan, Alborz, Ilam, Tehran (East and West), Razavi and
South Khorasan, Khuzestan, Sistan and Baluchestan, Fars, Kerman, Kermanshah,
Gilan, Lorestan, Mazandaran, and Qom. While ensuring nationwide coverage, the
company has prioritized the distribution of vital and rare medicines. This
extensive distribution network has facilitated access to necessary
pharmaceutical items for all citizens, especially residents of less developed
areas, and has minimized concerns of healthcare officials in this domain.
Strategic Measures in Supply and
Logistics
Adopting an innovative approach, the
company has placed process optimization and completion of its pharmaceutical
portfolio on its agenda. Developing the portfolio of specialized and vital
drugs, intelligent inventory management, and effective response to market
shortages constitute the company's most significant measures in the supply
sector. In the logistics domain, fleet modernization, ensuring quality and
safety in the distribution process, preventive maintenance of assets, and
enhancing the security of distribution centers are being pursued diligently to
ensure products reach end consumers with the highest quality standards.
Development Vision and Entry into New
Markets
Aiming to reduce concentration risk and
increase profitability, Soha Helal Distribution Company has taken substantial
steps toward diversifying its activity portfolio. Obtaining necessary licenses
for entering the food and veterinary pharmaceutical distribution sector
represents one of the company's most important strategic measures, which, while
reducing dependence on a limited market, opens new horizons before it.
Furthermore, by shifting its approach in product mix management, the company
places special emphasis on selling domestic items with higher profit margins
and leveraging the capacities of holding products to create intra-group synergy.
Strengthening Interactions and Reducing
Costs
In the sales and marketing domain,
developing diverse sales channels and extensive interaction with pharmacies,
particularly Red Crescent pharmacies nationwide, ranks among the company's main
priorities. Establishing transparent performance indicators, monitoring and
enhancing the field performance of sales teams, increasing customer coverage,
and optimizing distribution costs in neighboring provinces are among the
strategies Soha Health Distribution pursues to enhance operational efficiency
and improve its profit margin.
It is worth noting that all these
development-oriented measures and profit enhancement strategies are designed
and implemented in line with achieving the humanitarian goals of the Red
Crescent Society, with the ultimate objective of providing ever better and more
extensive services to the noble people of the Islamic Republic of Iran. This
will enable Soha Health Distribution Company to fulfill its mission of ensuring
and equitably distributing medicine throughout the country with redoubled
strength.